Diasorin S.P.A. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Diasorin S.P.A. with three other
pharmaceutical manufacturers in Europe:
sales of 553.10 million Euro [US$620.07 million]
of which 63%
(614.49 million Euro [US$688.89 million]
of which 51%
was Non-Proprietary Homeopathic Medicines), and
based in the United Kingdom
(£447.50 million [US$583.44 million]
of which 37%
was Licensing & Biotechnology).
During the year ended December of 2016, sales at
Diasorin S.P.A. were 569.31 million Euro (US$638.24 million).
increase of 14.0%
versus 2015, when the company's sales were 499.18 million Euro.
This was the fourth straight year of sales growth at Diasorin S.P.A..